ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. Income before tax

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.2B
P/E ratio
-44.8x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 2025-234-259.51%
Mar 31, 2024147-120.26%
Mar 31, 2023-725+46.84%
Mar 31, 2022-494+6.76%
Mar 31, 2021-463+101.40%
Mar 31, 2020-230-32.35%
Mar 31, 2019-340-259.20%
Mar 31, 2018213-31.17%
Mar 31, 2017310-145.74%
Mar 31, 2016-678-1.31%
Mar 31, 2015-687-16.66%
Mar 31, 2014-824-23.27%
Mar 31, 2013-1,074-1.71%
Mar 31, 2012-1,093

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat